Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine + Primaquine Efficacy in P. vivax
NCT06044805Phase 4Completed
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chloroquine and primaquine in Plasmodium vivax malaria. Primary endpoints: Early Treatment Failure at 3 days, Late Clinical Failure at 42 days and 2 more. Started Dec 2022; status: completed.
02
Drugs
chloroquineprimaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT06044805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044805.